NIBEC Co., Ltd. (KOSDAQ:138610)
South Korea · Delayed Price · Currency is KRW 30,900
+1,300 (4.39%)
At close: Mar 20, 2026
NIBEC Market Cap
NIBEC has a market cap or net worth of 351.21 billion as of March 20, 2026. Its market cap has increased by 103.16% in one year.
Market Cap
351.21B
Enterprise Value
334.74B
Revenue
32.96B
Ranking
n/a
PE Ratio
112.79
Stock Price
30,900.00
Market Cap Chart
Since July 13, 2011, NIBEC's market cap has increased from 37.43B to 351.21B, an increase of 838.20%. That is a compound annual growth rate of 16.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 351.21B | -17.68% |
| Dec 30, 2025 | 426.64B | 145.10% |
| Dec 30, 2024 | 174.07B | -20.67% |
| Dec 28, 2023 | 219.42B | 16.28% |
| Dec 29, 2022 | 188.69B | -34.63% |
| Dec 30, 2021 | 288.67B | -32.68% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Y-Biologics | 529.72B |
| S.Biomedics | 418.00B |
| curacle co.,ltd. | 390.29B |
| Genome & Company | 305.31B |
| Bio Solution | 301.19B |
| ABION | 259.94B |
| TiumBio | 252.40B |
| Kangstem Biotech | 250.65B |